Aerpio Pharmaceuticals, Inc.
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
Last updated:
Abstract:
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors, and to methods for regulating angiogenesis.
Status:
Application
Type:
Utility
Filling date:
12 Nov 2020
Issue date:
21 Apr 2022